Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma

Collin K Chin; Maria A Rodriguez; Yun Qing; Lei Feng; Felipe Samaniego; Preetesh Jain; Mansoor Noorani; Nathan H Fowler; Luis E Fayad; Jason R Westin; Sattva S Neelapu; Frederick B Hagemeister; Christopher R Flowers; Loretta J Nastoupil

doi:10.1080/10428194.2020.1789631

Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma

Collin K Chin, Maria A Rodriguez, Yun Qing, Lei Feng, Felipe Samaniego, Preetesh Jain, Mansoor Noorani, Nathan H Fowler, Luis E Fayad, Jason R Westin, Sattva S Neelapu, Frederick B Hagemeister, Christopher R Flowers, Loretta J Nastoupil

Research output: Contribution to journal › Letter › peer-review

6 Citations (Web of Science)

Original language	English
Pages (from-to)	2985-2989
Number of pages	5
Journal	LEUKEMIA & LYMPHOMA
Volume	61
Issue number	12
Early online date	6 Jul 2020
DOIs	https://doi.org/10.1080/10428194.2020.1789631
Publication status	Published - Dec 2020

Access to Document

10.1080/10428194.2020.1789631

Cite this

Chin, C. K., Rodriguez, M. A., Qing, Y., Feng, L., Samaniego, F., Jain, P., Noorani, M., Fowler, N. H., Fayad, L. E., Westin, J. R., Neelapu, S. S., Hagemeister, F. B., Flowers, C. R., & Nastoupil, L. J. (2020). Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma. LEUKEMIA & LYMPHOMA, 61(12), 2985-2989. https://doi.org/10.1080/10428194.2020.1789631

@article{d20135220df74c4da78d35c6b224be24,

title = "Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma",

keywords = "Antibodies, Monoclonal, Murine-Derived/therapeutic use, Antineoplastic Agents/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Humans, Lymphoma, B-Cell/drug therapy, Rituximab/therapeutic use",

author = "Chin, {Collin K} and Rodriguez, {Maria A} and Yun Qing and Lei Feng and Felipe Samaniego and Preetesh Jain and Mansoor Noorani and Fowler, {Nathan H} and Fayad, {Luis E} and Westin, {Jason R} and Neelapu, {Sattva S} and Hagemeister, {Frederick B} and Flowers, {Christopher R} and Nastoupil, {Loretta J}",

year = "2020",

month = dec,

doi = "10.1080/10428194.2020.1789631",

language = "English",

volume = "61",

pages = "2985--2989",

journal = "LEUKEMIA & LYMPHOMA",

issn = "1026-8022",

publisher = "Informa Healthcare USA",

number = "12",

}

Chin, CK, Rodriguez, MA, Qing, Y, Feng, L, Samaniego, F, Jain, P, Noorani, M, Fowler, NH, Fayad, LE, Westin, JR, Neelapu, SS, Hagemeister, FB, Flowers, CR & Nastoupil, LJ 2020, 'Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma', LEUKEMIA & LYMPHOMA, vol. 61, no. 12, pp. 2985-2989. https://doi.org/10.1080/10428194.2020.1789631

TY - JOUR

T1 - Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma

AU - Chin, Collin K

AU - Rodriguez, Maria A

AU - Qing, Yun

AU - Feng, Lei

AU - Samaniego, Felipe

AU - Jain, Preetesh

AU - Noorani, Mansoor

AU - Fowler, Nathan H

AU - Fayad, Luis E

AU - Westin, Jason R

AU - Neelapu, Sattva S

AU - Hagemeister, Frederick B

AU - Flowers, Christopher R

AU - Nastoupil, Loretta J

PY - 2020/12

Y1 - 2020/12

KW - Antibodies, Monoclonal, Murine-Derived/therapeutic use

KW - Antineoplastic Agents/therapeutic use

KW - Antineoplastic Combined Chemotherapy Protocols/adverse effects

KW - Humans

KW - Lymphoma, B-Cell/drug therapy

KW - Rituximab/therapeutic use

U2 - 10.1080/10428194.2020.1789631

DO - 10.1080/10428194.2020.1789631

M3 - Letter

C2 - 32628087

SN - 1026-8022

VL - 61

SP - 2985

EP - 2989

JO - LEUKEMIA & LYMPHOMA

JF - LEUKEMIA & LYMPHOMA

IS - 12

ER -